Phase 2 trial of NEU-411 for LRRK2-driven disease begins dosing
Neuron23 has dosed the first participant in its Phase 2 clinical trial of NEU-411, an investigational treatment for early…
Articles by Lila Levinson, PhD
AI-enabled earwax smell test could help diagnose Parkinson’s: Study
A new method that uses artificial intelligence (AI) to analyze the smell of earwax may help detect Parkinson’s disease,…
Ambio ibogaine program treats Parkinson’s, other diseases
A new clinical program will use ibogaine, a naturally occurring psychedelic, to treat neurodegenerative conditions including Parkinson’s disease.
FDA clears CAP-003 Parkinson’s gene therapy to be tested in trials
CAP-003, a gene therapy for Parkinson’s disease associated with GBA mutations, has been cleared by the U.S. Food and Drug…
Patients in pilot study see promise in equine-assisted therapy
Parkinson’s disease patients in a pilot study testing the effects of equine-associated therapy report that they enjoy working with…
Physical challenges, stigma complicate assistive device use
Barriers including physical difficulties and social stigma may affect how people with Parkinson’s disease use assistive devices meant to…
First Parkinson’s patient dosed in Unixell stem cell therapy study
Unixell Biotechnology has dosed its first Parkinson’s disease patient in a clinical study of its stem cell therapy candidate,…
Wandercraft clinic enlists robotics in Parkinson’s rehabilitation
Walk in New York, a new clinic from Wandercraft, will allow people with Parkinson’s disease to access…
Fundraising walks aim to support Parkinson’s research, advocacy
U.K.-based charity Cure Parkinson’s is marking its 20th anniversary by inviting supporters to take on walking challenges to raise money for…
Golf course pesticides may increase risk of Parkinson’s: Study
Living within three miles of a golf course may increase the risk of developing Parkinson’s disease, possibly due to…